RAC 3.31% $1.61 race oncology ltd

Why did it fail as an anticancer agent when it is such a potent...

  1. 276 Posts.
    lightbulb Created with Sketch. 139
    Why did it fail as an anticancer agent when it is such a potent FTO stopper, yet bisantrene hammers all sorts of cancers?

    It was interesting enough to CoH that they will continue to research it's FTO stopping ability. along with bisantrene.

    F trying to write a comment on this website on the Web browser on your phone.

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.61
Change
-0.055(3.31%)
Mkt cap ! $273.4M
Open High Low Value Volume
$1.66 $1.68 $1.61 $271.5K 166.3K

Buyers (Bids)

No. Vol. Price($)
1 1996 $1.61
 

Sellers (Offers)

Price($) Vol. No.
$1.68 1305 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.